Microbial Biosynthesis of cis,cis-Muconic Acid for 100% Bio-Based Adipic Acid and Nylon 6,6
Engineered Pseudomonas putida channeling sugars or lignin aromatics into cis,cis-muconic acid, followed by mild catalytic hydrogenation to adipic acid for carbon-negative Nylon 6,6 production.
1 · What it gives
Microbial Biosynthesis of cis,cis-Muconic Acid for 100% Bio-Based Adipic Acid and Nylon 6,6 represents an indispensable technological backbone across modern bio-based industrial chemistry, biopharmaceutical fill-finish, continuous downstream bioprocessing, and automated laboratory instrumentation. By integrating high-yielding engineered microbial cell factories, continuous catalytic syntheses, or precision robotic and fluid handling machinery, the platform delivers high-purity chemical intermediates, sterile containment closures, automated analytical workflows, and cGMP-compliant bioprocess equipment that replace fossil-derived petrochemicals and manual pharmaceutical unit operations.
The industrial platform encompasses continuous fermentation in large-scale fermenters, simulated moving bed (SMB) chromatography, reactive distillation, robotic blow-fill-seal (BFS) aseptic containment, and inline process analytical technology (PAT) monitoring. Modern manufacturing facilities achieve high volumetric conversions (>1.8 g/L/h), ultra-low contamination risk (<1 in 1,000,000 units), and energy efficiency gains of 40–60% compared to legacy batch operations. All processes comply with stringent international regulatory standards including ISO 9001/13485, cGMP Annex 1 sterile manufacturing rules, FDA 21 CFR Part 11, and European Pharmacopoeia (Ph. Eur.) monographs.
The key directions of this technology are:
- Platform Architecture & Catalytic Integration in Microbial Biosynthesis of cis,cis-Muconic Acid for 100% Bio-Based Adipic Acid and Nylon 6,6: Engineering robust biological hosts, enzymatic cascades, or precision robotic assemblies to maximize throughput, selectivity, and operational uptime.
- Continuous Separation, Crystallization & Refining: Deploying continuous multi-column chromatography, simulated moving bed (SMB) separation, and vacuum crystallization to obtain polymer/pharma-grade purity (>99.5%).
- Aseptic Barrier Isolation & Automated Containment: Utilizing closed isolator systems, robotic aseptic filling, blow-fill-seal (BFS) technology, and hydrogen peroxide (VHP) decontamination to eliminate human intervention.
- Real-Time Process Analytical Technology (PAT) & Automation: Embedding in-situ spectroscopy (Raman, NIR), automated multi-way sampling valves, and digital twin control software to maintain rigorous process quality.
Sectoral value chain#
┌────────────────────────────────────────────────────────┐
│ Tier 1: Upstream Substrate Prep & Seed Inoculation │
│ (Sugar hydrolysates, chemical inputs, sterile media) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 2: High-Density Bioconversion / Synthesis │
│ (Industrial bioreactors, catalytic synthesis trains) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 3: Primary Clarification & Crude Separation │
│ (Centrifugation, membrane filtration, liquid-liquid) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 4: Precision Purification & Crystallization │
│ (SMB chromatography, reactive distillation, drying) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 5: Aseptic Fill-Finish & Quality Packaging │
│ (BFS containment, robotic capping, batch validation) │
└────────────────────────────────────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Raw Material & Upstream Ingestion | Automated receipt, weighing, chemical dissolution, and sterilizing filtration of process raw materials. | In: Technical grade sugars, buffer salts, solvent reagents. Out: Sterile verified process feed with documented low bioburden (<10 CFU/100 mL). |
| Primary Reaction & Fermentation | High-efficiency conversion in automated stirred-tank fermenters or catalytic flow reactors under controlled stoichiometry. | In: Prepared media, engineered microbial culture, process heat. Out: Crude reaction mixture or fermented broth containing target organic molecule. |
| Primary Clarification & Isolation | Phase separation via high-throughput disc-stack centrifuges, microfiltration membranes, or flash evaporation. | In: Raw reaction mixture, anti-foam agents, wash fluids. Out: Clarified intermediate solution depleted of biomass and coarse particulates (>95% recovery). |
| Purification & Fractional Refining | Continuous multi-stage SMB chromatography, electrodialysis, or multi-effect fractional distillation. | In: Clarified solution, chromatographic resins, pure steam. Out: Ultra-pure chemical intermediate or concentrated active bulk substance (>99.5% purity). |
| Aseptic Packaging & Release | Automated sterile fill-finish, blow-fill-seal (BFS) ampoule formation, inline visual inspection, and serialization. | In: Purified bulk substance, pharmaceutical-grade polymers. Out: Hermetically sealed, tamper-evident commercial product ready for global distribution. |
Cross-cutting technologies of the sector:
- Inline Spectroscopic PAT Validation: Integrating fiber-optic Raman and FT-NIR probes measuring critical process parameters (CPPs) and critical quality attributes (CQAs) in real time.
- Automated Data Integrity & 21 CFR Part 11: Ensuring audit trail immutability, automated batch record generation, and SCADA redundancy across all PLC controllers.
2 · What it replaces 6 · matched by industry
3 · How to implement 4 steps
- 1Shikimate pathway re-routingEngineering Pseudomonas putida with protocatechuate decarboxylase to accumulate muconic acid.
- 2Fed-batch fermentationFermentation & cultivationCultivating on glucose, xylose, or depolymerized lignin, achieving >60 g/L cis,cis-muconate.
- 3Aqueous catalytic hydrogenationHydrogenating broth over heterogeneous Pd/C catalyst at 50°C and 5 bar to crude adipic acid.
- 4Polymerization into Nylon 6,6Synthesis & conversionCrystallizing polymer-grade adipic acid and reacting with bio-HMD to produce 100% bio-nylon.
4 · Who delivers
Matched suppliers (matched automatically)
| PTT Global Chemical (GC) | Thailand | Research / RTO | active |
| Zhejiang Huafon Biomaterials | China | Producer | active |
| Cathay Biotech 凯赛生物 (SSE 688065) | China | Producer | active |
| KansenBio 绿色康成 | China | Producer | active |
| Solugen | United States | Producer | active |
| CABIO 嘉必优 (SSE 688089) | China | Producer | active |
| COFCO Biotechnology 中粮科技 (SZ 000930) | China | Producer | active |
| CellUranics | China | Equipment | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Cathay Biotech | 🇨🇳 China | Bio-Based Polyamides & Long-Chain Dicarboxylic Acids (LCDA) | Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing. | Commercial Scale |
| Eni Sustainable Mobility | 🇮🇹 Italy | Biorefining, Ecofining HVO & Sustainable Transport Fuels | Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing. | Commercial Scale |
| BASF | 🇩🇪 Germany | Bio-Based Intermediates, Renewable Monomers & Catalysts | Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing. | Commercial Scale |
| Cargill | 🇺🇸 United States | Bio-Industrial Acids, Starch Polyols & Specialty Fermentation | Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing. | Commercial Scale |
| Corbion | 🇳🇱 Netherlands | Lactic Acid, Lactide Monomers & Sustainable Preservatives | Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing. | Commercial Scale |
5 · Rules & route to market
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
FDA 21 CFR Parts 210/211/820, cGMP Annex 1 Alignment, USP Compendial Monographs#
- FDA Current Good Manufacturing Practice (cGMP): Compliance with stringent quality systems, process validation, and sterile manufacturing standards for Microbial Biosynthesis of cis,cis-Muconic Acid for 100% Bio-Based Adipic Acid and Nylon 6,6.
- United States Pharmacopeia (USP) Standards: Full analytical alignment with compendial monographs governing chemical identity, purity, and residual solvents.
- Biotechnology Innovation Organization (BIO) Consortia: Industry consortia advocating for standardized single-use bioprocessing component validation.
European Union
EU GMP Annex 1 (Manufacture of Sterile Products), EMA Quality Guidelines, REACH Regulation#
- EU GMP Annex 1 Revised Mandate: Mandatory implementation of a comprehensive Contamination Control Strategy (CCS) and automated barrier isolation.
- European Medicines Agency (EMA) Guidelines: Strict regulatory validation of single-use fluid contact plastics, extractables, and leachables (E&L).
- EU REACH Registration & Chemical Safety: Full environmental and occupational safety registration for large-volume bio-based platform chemicals.
China
National Medical Products Administration (NMPA) GMP, Made in China 2025 Biomanufacturing, Chinese Pharmacopoeia (ChP)#
- NMPA Sterile Drug Manufacturing Guidelines: Strict enforcement of cleanroom environmental monitoring and closed-system isolator requirements for 基于可再生糖直接微生物发酵制备顺顺粘康酸并合成生物基己二酸.
- Chinese Pharmacopoeia (ChP) Monograph Compliance: Mandatory validation of chromatographic purity, heavy metal limits, and bioburden controls.
- High-End Pharmaceutical Equipment Modernization: National strategic funding upgrading domestic bioprocessing instrumentation and robotic filling platforms.
6 · Money: tenders & grants
| Grant | Development of cell-free protein synthesis platforms for discovery and/or production of biologicals European Commission · EU | Apr 13, 2027 141 days |
| Grant | Fostering common farmland birds and mammals for resilient food production systems European Commission · EU | Sep 22, 2027 303 days |
| Grant | Unleashing the potential of sustainable small-scale aquatic food production and recreational fisheries for … European Commission · EU | Sep 23, 2027 304 days |
7 · Tech stack & innovations
- Advanced Bioreactor & Fluid Control Systems:
- Hermetically sealed magnetic drive agitation preventing seal leak contamination in industrial fermenters.
- Automated continuous feeding systems tied to respiratory quotient (RQ) and dissolved oxygen kinetics.
- Electropolished 316L stainless steel vessels with surface roughness Ra <0.4 μm preventing biofilm buildup.
- Continuous Separation & SMB Chromatography:
- Multi-column simulated moving bed (SMB) chromatography skids paired with continuous electrodialysis bipolar membranes.
- Continuous counter-current separation achieving high product purity (>99.5%) with 70% solvent reduction.
- Automated column pack integrity monitoring via height equivalent to a theoretical plate (HETP) algorithms.
- Robotic Aseptic Fill-Finish & Isolator Containment:
- Fully enclosed glove-free isolators utilizing 6-axis cleanroom robotics for high-speed container handling and filling.
- Automated vaporized hydrogen peroxide (VHP) decontamination cycles achieving 6-log sporicidal kill.
- 100% inline non-destructive high-voltage leak detection (HVLD) and automated visual inspection camera arrays.
- Digital Process Automation & PAT Analytics:
- Distributed Control System (DCS) architecture embedding inline spectroscopy and machine learning control algorithms.
- Real-time non-destructive inline Raman and NIR spectroscopy for continuous reactant quantification.
- Full compliance with FDA 21 CFR Part 11 electronic records and tamper-evident audit trails.
Sources 5 · 2 independent · 3 producer sites
Independent sources 2
- pubs.rsc.org research checked 2026-11-15
- doi.org research checked 2026-11-15
Producers' own sites 3
- PTT global chemical producer checked 2026-11-15 · link not kept
- Toray industries producer checked 2026-11-15 · link not kept
- Nrel partners producer checked 2026-11-15 · link not kept